⌘K

Login Start Free

Home/Filings/4/0001235802-04-000221

4//SEC Filing

BIOSANTE PHARMACEUTICALS INC 4

Accession 0001235802-04-000221

$ANIPCIK 0001023024operating

View on SEC.gov Company Profile

Filed

Dec 1, 7:00 PM ET

Accepted

Dec 2, 8:43 PM ET

Size

12.1 KB

Accession

0001235802-04-000221

Insider Transaction Report

Form 4

Period: 2004-11-30

BIOSANTE PHARMACEUTICALS INCbpa

SIMES STEPHEN M

DirectorV Chair, Pres. and CEO

Transactions

Tax Payment
Common Stock
2004-11-30$10.44/sh−16,667$174,003→ 116,879 total
Sale
Common Stock
2004-11-30$10.07/sh−50,000$503,500→ 66,879 total
Exercise/Conversion
Common Stock
2004-11-30$2.90/sh+60,000$174,000→ 133,546 total
Exercise/Conversion
Employee Stock Option (right to buy)
2004-11-30$2.90/sh−60,000$174,000→ 0 total
Exercise: $2.90Exp: 2005-04-20→ Common Stock (60,000 underlying)

Holdings

Common Stock
(indirect: By Children)
100
Common Stock
(indirect: By Trust)
69,491

Footnotes (1)

[F1]Shares underlying this option have fully vested.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

BIOSANTE PHARMACEUTICALS INC

CIK 0001023024

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001023024

Filing Metadata

Form type: 4
Filed: Dec 1, 7:00 PM ET
Accepted: Dec 2, 8:43 PM ET
Size: 12.1 KB

View on SEC.gov